Key Financial Data Of Group

Delta-Fly Pharma, Inc. - Filing #7246013

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-1,718,662,000 JPY
-1,426,891,000 JPY
-1,325,760,000 JPY
-964,064,000 JPY
-859,372,000 JPY
Net assets
277,796,000 JPY
1,232,656,000 JPY
791,198,000 JPY
1,233,161,000 JPY
2,078,727,000 JPY
Total assets
434,334,000 JPY
1,474,155,000 JPY
906,817,000 JPY
1,324,352,000 JPY
2,161,192,000 JPY
Net assets per share
28.36
149.69
123.91
227.41
390.87
Basic earnings (loss) per share
-195.58
-198.78
-234.51
-178.58
-187.34
Diluted earnings per share
Equity-to-asset ratio
0.635 xbrli:pure
0.836 xbrli:pure
0.870 xbrli:pure
0.931 xbrli:pure
0.961 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,834,577,000 JPY
-1,279,615,000 JPY
-1,303,049,000 JPY
-940,399,000 JPY
-726,649,000 JPY
Net cash provided by (used in) investing activities
-206,000 JPY
207,000 JPY
-326,000 JPY
JPY
-505,000 JPY
Net cash provided by (used in) financing activities
756,696,000 JPY
1,853,195,000 JPY
882,617,000 JPY
119,857,000 JPY
875,313,000 JPY
Cash and cash equivalents
338,829,000 JPY
1,417,062,000 JPY
844,341,000 JPY
1,268,492,000 JPY
2,088,612,000 JPY
Number of employees
13 xbrli:pure
13 xbrli:pure
11 xbrli:pure
12 xbrli:pure
11 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
1 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.